Thamir M. Alshammari

3.5k total citations
78 papers, 1.4k citations indexed

About

Thamir M. Alshammari is a scholar working on Toxicology, Geriatrics and Gerontology and Epidemiology. According to data from OpenAlex, Thamir M. Alshammari has authored 78 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Toxicology, 21 papers in Geriatrics and Gerontology and 15 papers in Epidemiology. Recurrent topics in Thamir M. Alshammari's work include Pharmacovigilance and Adverse Drug Reactions (24 papers), Pharmaceutical Practices and Patient Outcomes (21 papers) and Vaccine Coverage and Hesitancy (12 papers). Thamir M. Alshammari is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (24 papers), Pharmaceutical Practices and Patient Outcomes (21 papers) and Vaccine Coverage and Hesitancy (12 papers). Thamir M. Alshammari collaborates with scholars based in Saudi Arabia, United States and Australia. Thamir M. Alshammari's co-authors include Hisham Aljadhey, Ali F. Altebainawi, Talib Hussain, Mansour Adam Mahmoud, Mohamad Aljofan, Kazeem B. Yusuff, Faiyaz Shakeel, Md. Faiyazuddin, Gehad M. Subaiea and Muhammad Majid Aziz and has published in prestigious journals such as ACS Applied Materials & Interfaces, Molecules and BMC Public Health.

In The Last Decade

Thamir M. Alshammari

73 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thamir M. Alshammari Saudi Arabia 22 330 247 203 183 175 78 1.4k
Rana Abu Farha Jordan 23 203 0.6× 559 2.3× 193 1.0× 145 0.8× 219 1.3× 190 1.9k
Syed Tabish R. Zaidi Australia 28 130 0.4× 513 2.1× 233 1.1× 55 0.3× 236 1.3× 108 2.3k
Akram Ahmad Malaysia 17 95 0.3× 250 1.0× 109 0.5× 105 0.6× 179 1.0× 77 1.1k
Chiara Pandolfini Italy 15 161 0.5× 186 0.8× 172 0.8× 297 1.6× 200 1.1× 51 1.8k
Johanna C. Meyer South Africa 24 102 0.3× 297 1.2× 363 1.8× 226 1.2× 310 1.8× 156 1.7k
Subish Palaian Nepal 26 476 1.4× 677 2.7× 203 1.0× 72 0.4× 373 2.1× 192 2.2k
Alexander Dodoo Ghana 17 265 0.8× 75 0.3× 101 0.5× 70 0.4× 250 1.4× 47 907
Florence van Hunsel Netherlands 23 995 3.0× 158 0.6× 104 0.5× 95 0.5× 405 2.3× 122 1.8k
Ramadan Elkalmi Malaysia 17 151 0.5× 193 0.8× 141 0.7× 194 1.1× 87 0.5× 55 839
Lisa Pont Australia 23 128 0.4× 571 2.3× 378 1.9× 37 0.2× 266 1.5× 91 1.9k

Countries citing papers authored by Thamir M. Alshammari

Since Specialization
Citations

This map shows the geographic impact of Thamir M. Alshammari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thamir M. Alshammari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thamir M. Alshammari more than expected).

Fields of papers citing papers by Thamir M. Alshammari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thamir M. Alshammari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thamir M. Alshammari. The network helps show where Thamir M. Alshammari may publish in the future.

Co-authorship network of co-authors of Thamir M. Alshammari

This figure shows the co-authorship network connecting the top 25 collaborators of Thamir M. Alshammari. A scholar is included among the top collaborators of Thamir M. Alshammari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thamir M. Alshammari. Thamir M. Alshammari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Alshammari, Thamir M., et al.. (2025). Real-World Safety Concerns of Tirzepatide: A Retrospective Analysis of FAERS Data (2022–2025). Healthcare. 13(18). 2259–2259.
3.
4.
Makadia, Rupa, Azza Shoaibi, Gowtham Rao, et al.. (2023). Evaluating the impact of alternative phenotype definitions on incidence rates across a global data network. JAMIA Open. 6(4). ooad096–ooad096. 1 indexed citations
5.
Altebainawi, Ali F., et al.. (2023). Association between proton pump inhibitors and rhabdomyolysis risk: a post-marketing surveillance using FDA adverse event reporting system (FAERS) database. Therapeutic Advances in Drug Safety. 14. 1581606299–1581606299. 14 indexed citations
6.
Alshammari, Thamir M., et al.. (2023). The association between drug pricing and drug shortage in Saudi Arabia: a retrospective database analysis. Journal of Pharmaceutical Policy and Practice. 16(1). 91–91. 2 indexed citations
7.
Alshammari, Thamir M., et al.. (2023). Recording type 2 diabetes mellitus in a standardised central Saudi database: a retrospective validation study. BMJ Open. 13(3). e065468–e065468. 1 indexed citations
8.
Schuemie, Martijn J., Fan Bu, Evan Minty, et al.. (2023). Serially Combining Epidemiological Designs Does Not Improve Overall Signal Detection in Vaccine Safety Surveillance. Drug Safety. 46(8). 797–807. 2 indexed citations
9.
Alshammari, Thamir M., et al.. (2023). Estimating the potential economic impact of the Wasfaty program on costs of antidiabetic treatment: An initiative for the digital transformation of health. Saudi Pharmaceutical Journal. 31(6). 1029–1035. 8 indexed citations
10.
Alshammari, Thamir M., et al.. (2022). Pharmacovigilance regulatory actions by national pharmacovigilance centers in Arab countries following COVID-19 pandemic. Expert Opinion on Drug Safety. 22(2). 165–174. 1 indexed citations
11.
12.
Schuemie, Martijn J., Nicole Pratt, Fredrik Nyberg, et al.. (2022). Vaccine Safety Surveillance Using Routinely Collected Healthcare Data—An Empirical Evaluation of Epidemiological Designs. Frontiers in Pharmacology. 13. 893484–893484. 7 indexed citations
13.
Alshammari, Thamir M., et al.. (2021). Medication Error Concept and Reporting Practices in Saudi Arabia: A Multiregional Study Among Healthcare Professionals. Risk Management and Healthcare Policy. Volume 14. 2395–2406. 17 indexed citations
14.
Alshammari, Thamir M., et al.. (2021). Health outcomes and policy in pharmay curricula among Arab countries: An evaluation of 191 academic institutions. Saudi Pharmaceutical Journal. 29(8). 799–806. 2 indexed citations
15.
Alshammari, Thamir M., et al.. (2021). Current Situation of Medication Errors in Saudi Arabia: A Nationwide Observational Study. Journal of Patient Safety. 18(2). e448–e453. 11 indexed citations
16.
Alshammari, Thamir M., et al.. (2020). Real‐world data in Saudi Arabia: Current situation and challenges for regulatory decision‐making. Pharmacoepidemiology and Drug Safety. 29(10). 1303–1306. 13 indexed citations
17.
Alshammari, Thamir M., et al.. (2019). Pharmacovigilance Systems in Arab Countries: Overview of 22 Arab Countries. Drug Safety. 42(7). 849–868. 32 indexed citations
18.
19.
Aljadhey, Hisham, et al.. (2015). A qualitative exploration of the major challenges facing pharmacovigilance in Saudi Arabia. Saudi Medical Journal. 36(9). 1097–1102. 28 indexed citations
20.
Alshammari, Thamir M., et al.. (2014). Community pharmacists' knowledge of isotretinoin safety.. PubMed. 35(1). 81–4. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rana Abu Farha Breakdown of academic impact, for papers by Syed Tabish R. Zaidi Breakdown of academic impact, for papers by Akram Ahmad Breakdown of academic impact, for papers by Chiara Pandolfini Breakdown of academic impact, for papers by Johanna C. Meyer Breakdown of academic impact, for papers by Subish Palaian Breakdown of academic impact, for papers by Alexander Dodoo Breakdown of academic impact, for papers by Florence van Hunsel Breakdown of academic impact, for papers by Ramadan Elkalmi Breakdown of academic impact, for papers by Lisa Pont
Rankless by CCL
2026